Despite its well-publicised problems, the FDA is a happy place for ASX biotechs seeking drug or device approvals.

Sovereign Metals (ASX:SVM) has confirmed the fleet design and mining method for its Kasiya graphite-rutile project DFS in ...

ASX-listed Nanosonics, Optiscan, and Clever Culture Systems are transforming healthcare efficiency through innovative medtech ...

Dual listing in the US offers access to the world’s largest source of capital and could serve to increase exposure to ...

Three in four Australians want tech giants banned from using local content to train AI systems without permission or ...